Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04441242 · ClinicalTrials.gov registry record · NA

Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
1,109
Enrollment target

NCT04441242: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT04441242 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04441242, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
1,109 participants
Enrollment target

Study Summary

A retrospective and prospective study to determine if the use of ambient lighting during screening colonoscopy is well tolerated and if ambient lighting will help physicians maintain adenoma detection rates while decreasing symptoms of eye strain as the day progresses.

Primary Outcome

Adenoma detection rate, comparing change from first case of the day to the last. Ranges from 0-99%, with greater increases adenoma detection rate (ADR) being more favorable.

Interventions

  • OTHER Ambient lighting
  • OTHER Low lighting

Trial Details

FieldValue
Enrollment Target 1,109 participants
Start Date 2017-01-01
Est. Completion 2018-06-30
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT04441242 record still lists

NCT04441242 is an interventional study that assigns participants to a tested intervention. Its 1,109 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower).

The record links to 0 conditions, and to 2 interventions - of which Ambient lighting is the first listed.

NCT04441242 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04441242 about?

NCT04441242 is a clinical study titled "Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue". A retrospective and prospective study to determine if the use of ambient lighting during screening colonoscopy is well tolerated and if ambient lighting will help physicians maintain adenoma detection rates while decreasing symptoms of eye strain as the day progresses.

What is the current status of trial NCT04441242?

This trial is currently completed. It is a NA study. The enrollment target is 1,109 participants. The study started on 2017-01-01. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT04441242?

The interventions under investigation include: Ambient lighting (OTHER), Low lighting (OTHER).

Who is sponsoring clinical trial NCT04441242?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04441242's enrollment target sits among peer trials

1,109 93rd of 2000 higher than 1,908 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00710112 · 1,100 participants

    Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

  • NCT02688517 · 1,100 participants

    Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

  • NCT04743765 · 1,100 participants · NA

    HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

  • NCT05638581 · 1,100 participants · Phase 3

    Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04441242, the US trial registry maintained by the National Library of Medicine. NCT04441242 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.